Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin

European Journal of Ophthalmology

Volumn 14, Issue 5, 2004, Pages 434-437

  Silva, Rufino ^a   Torrent, T ^a   Loureiro, R ^a   Travassos, A ^b   Faria De Abreu, J Rui ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b Surgical Center of Coimbra   (Portugal)

Author keywords

Choroidal neovascularization; Optic nerve drusen; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUSEN; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; OPTIC NERVE DISEASE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA HEMORRHAGE; SCHOOL CHILD; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 8344244507     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400512     Document Type: Article

References (5)

1. Harris MJ, Fine SL, Owens SL, Guzak SV. Hemorrhagic complications of optic nerve drusen. Am J Ophtalmol 1981; 92: 70-6.
2. Diduzyn JM, Quillen DA, Cantore WA, Gardner TW. Optic disc drusen, peripapillary choroidal neovascularization, and POEMS syndrome. Am J Ophthalmol 2002; 133: 275-6.
3. Sullu Y, Yildiz L, Erkan D. Submacular surgery for choroidal neovascularization secondary to optic nerve drusen. Am J Ophthalmol 2003; 136: 367-70.
4. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541-60.
5. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials. Arch Ophthalmol 2001; 119: 198-207.